Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1951–2000 of 18397
Effective as of the Transition Date, the Board appointed Ian F. Smith, 59, a director on the Board, to succeed Dr. Kaye as Interim Chief Executive Officer (“Interim CEO”).
On March 12, 2025, Michael Crawford informed the Board of Directors of Hall of Fame Resort & Entertainment Company (the “Company”) that he intends to resign as President, Chief Executive Officer, and Chairman of the Board of Directors.
Trisha Gosser has been appointed as the Chief Financial Officer of Gannett Co., Inc. (the “Company”).
Gina Chapman, the Company’s President, CEO and member of the board of directors will be leaving the Company effective May 19, 2025.
the Board appointed Anup Radhakrishnan, the Company’s Chief Financial Officer and Chief Operating Officer, to succeed Ms. Chapman as interim CEO.
Mr. Oxtoby, age 51, has served as the Combined Company’s President and Chief Executive Officer and as a member of the Board since the Closing.
approved the appointment of Keith Schroeder, age 69, as Chief Financial Officer and Secretary of the Company, effective March 18, 2025
Mr. Kelvin (Zeng Yenn) Chin, the chief financial officer of Globalink Investment Inc., a company formed under the laws of Delaware (the “Company”), notified the Company of his resignation as the chief financial officer and a director of the Company, effective March 17, 2025.
the Company’s board of directors (the “Board”) appointed Mr. Say Leong Lim, the chief executive officer of the Company, as the Company’s chief financial officer, with effect from March 18, 2025.
Scott M. Haralson, Executive Vice President and Chief Financial Officer, will become the Company’s principal accounting officer upon Ms. Galloway’s departure from the Company.
Brian W. Bolster, Executive Vice President, Finance and Chief Financial Officer of NEE and Florida Power & Light Company (FPL), resigned from those positions effective May 22, 2025 and was appointed President and Chief Executive Officer of NEER to succeed Ms. Kujawa effective May 22, 2025.
Michael H. Dunne, Treasurer of NEE and FPL and Assistant Secretary of NEE, was appointed to succeed Mr. Bolster as Executive Vice President, Finance and Chief Financial Officer of NEE and FPL effective May 22, 2025.
Brian W. Bolster, Executive Vice President, Finance and Chief Financial Officer of NEE and Florida Power & Light Company (FPL), resigned from those positions effective May 22, 2025 and was appointed President and Chief Executive Officer of NEER to succeed Ms. Kujawa effective May 22, 2025.
Rebecca Kujawa, President and Chief Executive Officer of NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc. (NEE), notified NEE that she plans to retire from those positions effective May 22, 2025 as part of a planned leadership succession process.
Effective March 10, 2025, the service of John A. Scarlett, M.D. as the President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Geron Corporation (the “Company” or “Geron”) concluded and, in connection therewith, Dr. Scarlett resigned from the Board.
Also, effective March 10, 2025, Dawn C. Bir, a current member of the Board, was appointed as the Interim President and Chief Executive Officer of Geron
On March 17, 2025, the Company announced that Scott Bowman, Chief Financial Officer and Treasurer (and, in such capacities, principal financial officer and principal accounting officer) of the Company, departed from the Company, effective March 14, 2025.
On March 17, 2025, Leslie’s, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Tony Iskander, age 51, as the Company’s Interim Chief Financial Officer and Treasurer, effective as of March 14, 2025 (in which capacity he will serve as the Company’s principal financial officer and principal accounting officer).
On March 12, 2025, the Board appointed Sunit Patel, age 63, as Executive Vice President ("EVP") and Chief Financial Officer ("CFO") of the Company, effective as of April 1, 2025 ("Effective Date").
On March 17, 2025, The Children’s Place, Inc. (the “Company”) announced that John Szczepanski has been appointed Chief Financial Officer of the Company, effective March 31, 2025.
On March 11, 2025, the Board appointed Brian Gold as the Company’s chief financial officer, effective April 1, 2025.
Edward T. Gallivan, Jr. notified the board of directors of the Company (the “Board”) of his resignation as chief financial officer of the Company, effective April 1, 2025.
On March 11, 2025, John Dahldorf, the Chief Financial Officer of Adagio Medical Holdings, Inc. (the “Company”) announced his decision to resign as Chief Financial Officer, effective March 21, 2025.
The employment of Brian C. Stephenson, the Chief Financial Officer of BridgeBio Pharma, Inc. (the “Company”), ended on March 17, 2025 (the “Effective Date”).
On March 17, 2025 (the “ Effective Date ”), Universal Technical Institute, Inc., a Delaware corporation (the “ Company ”), announced the appointment of Bruce Schuman to the role of Chief Financial Officer, effective immediately.
In connection with Mr. Schuman’s appointment to the role of Chief Financial Officer, Christine Kline resigned from the positions of Interim Chief Financial Officer and principal financial officer, effective as of the Effective Date.
Mr. Steele will be employed as the Chief Financial Officer of the Company.
David Desharnais, Chief Executive Officer of the Company, resigned from the Company, which resignation was accepted by Company’s Board of Directors on March 14, 2025.
appointed Jeffrey Thompson, the Company’s Chief Executive Officer and Chairman of the Board of Directors, as Interim Chief Financial Officer, effective from March 17, 2025
On March 11, 2025, the Company appointed Christian Koji Ericson as the Company’s Chief Financial Officer, effective immediately after the filing of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2024.
On March 17, 2025, eXp World Holdings, Inc. (the “Company”) announced the appointment of Jesse Hill as Interim Chief Financial Officer (“CFO”) and principal financial officer of the Company, effective April 1, 2025.
On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.
on March 17, 2025, the Board of Directors of the Company appointed Alissa Vickery to serve as the Company’s interim CFO, effective immediately upon Mr. Panther's departure.
Tom Panther notified Corpay, Inc. (the “Company”) of his decision to resign as Chief Financial Officer (“CFO”) effective March 15, 2025.
On March 17, 2025, Richard Vance, President and Chief Executive Officer and director of the Company, retired from the Company and resigned from the Board.
On March 17, 2025, the Board of Directors (the “ Board”) of Highlands REIT, Inc. (the “ Company”) appointed Robert J. Lange to serve as Chief Executive Officer, President, and Secretary of the Company, effective immediately.
On March 17, 2025, the Company’s Board of Directors determined to make Mr. Sam Davis the Company’s permanent Chief Executive Officer, and approved a change in Mr. Davis’s title to President and Chief Executive Officer, effective immediately.
appointed Michael Carlet, the Company’s Executive Vice President and Chief Financial Officer, to also serve as the Company’s principal accounting officer
appointed Lip-Bu Tan as Chief Executive Officer (“CEO”) and as a director of the Company, effective as of March 18, 2025
In connection with Lip-Bu Tan’s appointment as Intel’s Chief Executive Officer effective March 18, 2025, Ms. Holthaus and Mr. Zinsner will cease to serve as Interim Co-CEOs as of such date.
In connection with Lip-Bu Tan’s appointment as Intel’s Chief Executive Officer effective March 18, 2025, Ms. Holthaus and Mr. Zinsner will cease to serve as Interim Co-CEOs as of such date.
Jeffrey J. Scissons has been named Vice President, Chief Financial Officer and Corporate Treasurer (“CFO”) of ALLETE, Inc. (the “Company”), effective as of March 11, 2025.
Robert Starr, the Company’s Executive Vice President and Chief Financial Officer will assume the role of Principal Accounting Officer on an interim basis until a successor is named.
Immediately following the conclusion of the AGM, Joakim Weidemanis succeeded George Oliver as the Company's Chief Executive Officer and principal executive officer
Immediately following the conclusion of the AGM, Joakim Weidemanis succeeded George Oliver as the Company's Chief Executive Officer and principal executive officer
Effective March 14, 2025, the Board of Directors (the “Board”) of Sterling Infrastructure, Inc. (the “Company”) appointed Ronald A. Ballschmiede, the Company’s Executive Vice President and former Chief Financial Officer and Chief Accounting Officer, as the Company’s interim Chief Financial Officer and Chief Accounting Officer.
Upon approval of the Board, Sharon R. Villaverde ceased serving as Chief Financial Officer and Chief Accounting Officer, without cause, on March 14, 2025.
On March 11, 2025, Rasmus Holm-Jorgensen, the Company’s Chief Financial Officer, notified the Company of his decision to step down from his position, effective April 1, 2025, for personal reasons to pursue another opportunity with a company based in Europe, allowing him to spend more time near his family.
On March 14, 2025, Acrivon Therapeutics, Inc. (the “Company”) appointed Adam Levy, Ph.D., M.B.A., to the position of Chief Financial Officer, effective as of April 1, 2025 (the “Effective Date”).
As previously announced by Enovis Corporation (the “Company”), on February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of the Company of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company (the “Appointment Date”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.